Literature DB >> 6173459

Antibody-independent complement activation by myelin via the classical complement pathway.

J C Cyong, S S Witkin, B Rieger, E Barbarese, R A Good, N K Day.   

Abstract

Murine or rabbit whole brain homogenates were shown to activate human complement via the classical pathway by an antibody-independent reaction. This activity required Ca++ ions. Anticomplementary activity in fractionated murine brain was found to reside in the myelin fraction and in purified myelin. It was absent, however, both from highly purified myelin basic protein (MBP) and from the MBP-free residue. Because purified MBP is a monomer and this protein exists in brain tissue largely as a dimer, the ability of the cross-linked form of MBP to activate complement was investigated. MBP, dimerized with difluorodinitrobenzene, was highly anticomplementary. The murine brain, inactive when taken from the newborn mouse, was shown to first acquire the capacity to activate complement at 7 d after birth. This finding is consistent with the report that the synthesis of myelin protein has been shown to be initiated in murine brain 8 d after birth. Complement activation by MBP could play an important role in the pathological changes observed in neurological disorders.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6173459      PMCID: PMC2186606          DOI: 10.1084/jem.155.2.587

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Isolation of microsomal poly(A)-RNA from rat brain directing the synthesis of the myelin encephalitogenic protein in Xenopus oocytes.

Authors:  L Lim; J O White; C Hall; W Berthold; A N Davison
Journal:  Biochim Biophys Acta       Date:  1974-08-29

2.  The fourth component of complement in the cerebrospinal fluid in systemic Lupus erythematosus.

Authors:  N M Hadler; R D Gerwin; M M Frank; J N Whitaker; M Baker; J L Decker
Journal:  Arthritis Rheum       Date:  1973 Jul-Aug

3.  Antibody-independent activation of human C1 after interaction with heart subcellular membranes.

Authors:  R N Pinckard; M S Olson; R E Kelley; D H DeHeer; J D Palmer; R A O'Rourke; S Goldfein
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

4.  Protein turnover in cell-enriched fractions from rabbit brain.

Authors:  C Blomstrand; A Hamberger
Journal:  J Neurochem       Date:  1969-09       Impact factor: 5.372

5.  Identification of prelarge and presmall basic proteins in mouse myelin and their structural relationship to large and small basic proteins.

Authors:  E Barbarese; P E Braun; J H Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

Review 6.  Serum and cerebral spinal fluid complement and serum autoantibodies in systemic lupus erythematosus.

Authors:  L D Petz; G C Sharp; N R Cooper; W S Irvin
Journal:  Medicine (Baltimore)       Date:  1971-07       Impact factor: 1.889

7.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

8.  Circulating immune complexes in multiple sclerosis and other neurological diseases.

Authors:  T G Tachovsky; R P Lisak; H Koprowski; A N Theofilopoulos; F J Dixon
Journal:  Lancet       Date:  1976-11-06       Impact factor: 79.321

9.  Evidence for immune complexes involving anti-lymphocyte antibodies associated with hypocomplementaemia in chronic lymphocytic leukaemia (CLL).

Authors:  N K Day; J B Winfield; T Gee; R Winchester; H Teshima; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

10.  Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations.

Authors:  J Siegel; A P Osmand; M F Wilson; H Gewurz
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

View more
  8 in total

1.  Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody.

Authors:  D R Wren; M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Central pontine myelinolysis: historical and mechanistic considerations.

Authors:  Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2010-02-25       Impact factor: 3.584

3.  Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.

Authors:  S K Singhrao; J W Neal; N K Rushmere; B P Morgan; P Gasque
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

4.  Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes.

Authors:  P Gasque; B P Morgan
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

5.  Complement C1q and C3 mRNA expression in the frontal cortex of Alzheimer's patients.

Authors:  B Fischer; H Schmoll; P Riederer; J Bauer; D Platt; A Popa-Wagner
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

6.  Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59.

Authors:  M G Wing; J Zajicek; D J Seilly; D A Compston; P J Lachmann
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

Review 7.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983

Review 8.  T cell approach to demyelinating diseases.

Authors:  H Wekerle; W Fierz
Journal:  Springer Semin Immunopathol       Date:  1985
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.